## 



## 

## 

## 

## 

||**Page**|
|---|---|
|General information|2|
|Report of the trustees|**3-4**|
|Statement of trustees' responsibilities|5|
|Independent Examiner report|6|
|Statement of financial activities|7|
|Balance sheet|**8**|
|Cashflow statement|9|
|Accounting policies|**10 - 11**|
|Notes to the financial statements|**12- 14**|





## 



## 

## 

## 

## 

## 

## 

## 

## 

## 

## 

## 



## 

## 

## 

## 

## 

## 

## 

## 

## 

## 

## 



## 



## 

## 

## 

## 

## 



## 

## 

|||**Unrestricted**|**Expendable**|**Total**|Total|
|---|---|---|---|---|---|
|||**Income**|**endowment**|**this year**|last year|
|**Note**||**Fund**|**Fund**|**2024**|**2023**|
|||£|£|£|£|
|**Income resources**||||||
|_Voluntary Income_||||||
|Donations|1|||||
|Tax refund due on gift aid||||||
|_Investment income_|2|58,298||58,298|59,622|
|**Total incoming resourses**||58,298||58,298|59,622|
|**Resources expended**||||||
|_Cost of generating funds_||||||
|Investment management costs|3|||||
|_Charitable activities_||||||
|Grants made|4|90,000||90,000|110,000|
|_Governance cost_||||||
|Audit/independent examination fees|5|450||450|1,380|
|Trust accounting/tax claims fees||3,000||3,000||
|Professional administration fees|||||3,000|
|**Total resources expended**||93,450||93,450|114,380|
|**Net incoming/(outgoing) resources**||(35,152)||(35,152)|(54,758)|
|**before transfers**||||||
|Gross transfers between funds||35,152|(35,152)|||
||||(35,152)|(35,152)|(54,758)|
|**Net income/(outgoing) resources before**||||||
|**other recognised gains and losses**||||||
|**Other recognised gains and losses**||||||
|(Losses)/gains on investment assets|||(13,996)|(13,996)|(324,156)|
|**Net movements in funds**|||(49,148)|(49,147)|(378,914)|
|Fund balance brought forward|||3,306,401|3,306,401|3,685,315|
|**Fund balance carried forward at 5 April 2024**|||3,257,253|3,257,253|3,306,401|
|||7||||





## 

|||**Total**|**Total**|
|---|---|---|---|
||**Note**|**this year**|**last year**|
|||**2024**|**2023**|
|**Fixed assets**||||
|Investment at marketvalue|6|**3,230,883**|3,287,901|
|**Current assets**||||
|Debtors|7|||
|Cash at Handelsbanken||**28,320**|21,320|
|Creditors: amountsfalling duewithin one year|8|**(1,950)**|(2,820)|
|**Net current assets**||**26,370**|18,500|
|**Total assets less current liabilities**||**3,257,253**|3,306,401|
|Creditors: amountsfalling due afterone year||||
|||**3,257,253**|3,306,401|
|**Funds**||||
|Expendable endowmentfund (page 10)||**3,257,253**|3,306,401|
|Unrestricted incomefund (page 10)||||
|||**3,257,253**|3,306,401|





## 

## 

## 

||**2024**|**2023**|
|---|---|---|
|**Net income for the year**|(35,152)|(54,758)|
|**Adjustments for**|||
|Interest and dividends|(58,298)|(59,622)|
|Decrease/(lncrease) in debtors|||
|lncrease/(decrease) in creditors|(870)|60|
|**Cash flows from operating activities**|(94,320)|(114,320)|
|**Cash flows from investing activities**|||
|Interest and dividends|58,298|59,622|
|Proceeds from sale of investments|92,640|84,418|
|Purchase of investments|(58,298)|(59,613)|
|**Net cash used by investing activities**|||
||92,640|84,427|
|Change in cash and cash equivalents|(1,680)|(29,893)|
|Cash and cash equivalents brought forward|30,000|59,893|
|Cash and cash equivalents carried forward|28,320|30,000|





## 

## 

## 

## 

## 

## 

## 

## 

## 

## 



## 



## 


## 

|||2024|2023|
|---|---|---|---|
|||£|£|
|**1 **|**Income**|||
||GiftAid donation|||
|**t**||||
|2|**Investment income**|||
||Handelsbanken interest|||
||Portfolio deposit interest||10|
||Unit trust distributions|58,298|59,612|
|||58,298|59,622|
|3|**Investment management**|||
|4|**Grants**|||
||Unlimit Heath|30,000||
||Sight Savers|30,000|25,000|
||Plan International|30,000|20,000|
||Malaria Consortium||40,000|
||Schistosomiasis||25,000|
|||90,000|110,000|
|5|**Governance fees:**|||
||Independent Examinersfeesfor2022/23 (2021/22)|450|1,380|
||General adminstration||3,000|
||Accountancyfeesfor2023/24|3,000||
|||===3=,4=5=<br>0|4,380|





## 

## 

## 

|||2024|2023|
|---|---|---|---|
|||£|£|
|6|**Analysis of Investment**|Mkt Value|Mkt Value|
|||at year end|at year end|
||LF Hb Balanced Sustainable MAF I Ace|3,230,883|3,279,221|
||Portfolio Cash||8,680|
||Total|3,230,883|3,287,901|



||**Market value**|||
|---|---|---|---|
||Carry (market) value at beginning of year|3,279,221|3,628,182|
||Add Additions at cost|58,298|59,613|
||Less disposals at carry value|(92,640)|(91,954)|
||Add/(deduct) net gain/(loss) on disposal|1,259||
||Add/(deduct) net gain/(loss) on revaluation|(15,256)|(316,620)|
||Carry (market) value at end of year|3,230,883|3,279,221|
|7|**Debtors**|||
||Outstanding gift aid refunds|||
|8|**Creditors: amount falling due within one year**|||
||Independent Examiners fees for 2023/24 (2022/23)|450|1,320|
||General adminstartion|1,500|1,500|
|||1,950|2,820|





## 

|9|**Analysis of Funds**||||||
|---|---|---|---|---|---|---|
|||**At**|Income|Expenditure|Gains/losses|**At**|
|||06-Apr-23|||& transfers|05-Apr-24|
|||£|£|£|£|£|
||Expendable endowment funds|**3,306,401**|||**(49,148)**|**3,257,253**|
||Unrestricted funds||**58,298**|**(93,450)**|**35,152**||
|~||**3,306,401**|**58,298**|**(93,450)**|**(13,996)**|**3,257,253**|
|||**At**|Income|Expenditure|Gains/losses|**At**|
|||06-Apr-22|||& transfers|05-Apr-23|
||||£|£|£||
||Expendable endowment funds|**3,685,315**|||**(378,914)**|**3,306,401**|
||Unrestricted funds||**59,622**|**(114,380)**|**54,758**||
|||**3,685,315**|**59,622**|**(114,380)**|**(324,156)**|**3,306,400**|



##